Jiang He Selected Research

Atherosclerosis

4/2022	Prediction of Incident Heart Failure in CKD: The CRIC Study.
1/2021	Plasma osteopontin levels and adverse clinical outcomes after ischemic stroke.
1/2021	Atherosclerotic cardiovascular disease events among statin eligible individuals with and without long-term healthy arterial aging.
1/2020	Endostatin as a novel prognostic biomarker in acute ischemic stroke.
1/2018	Effect of Serum Adiponectin Levels on the Association Between Childhood Body Mass Index and Adulthood Carotid Intima-Media Thickness.
1/2018	Serum Galectin-3 and Poor Outcomes Among Patients With Acute Ischemic Stroke.
8/2015	Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
4/2015	PET imaging detection of macrophages with a formyl peptide receptor antagonist.
10/2014	Protein intake and lumbar bone density: the Multi-Ethnic Study of Atherosclerosis (MESA).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiang He Research Topics

Disease

78	Hypertension (High Blood Pressure) 01/2022 - 04/2002
69	Ischemic Stroke 04/2022 - 02/2014
63	Chronic Renal Insufficiency 04/2022 - 02/2003
57	Cardiovascular Diseases (Cardiovascular Disease) 11/2022 - 03/2002
46	Neoplasms (Cancer) 01/2022 - 12/2002
40	Stroke (Strokes) 02/2022 - 05/2002
23	Inflammation (Inflammations) 01/2022 - 10/2004
18	Heart Failure 03/2022 - 07/2002
15	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 03/2002
13	Insulin Resistance 02/2021 - 02/2003
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 02/2004
10	Proteinuria 11/2022 - 01/2012
10	Myocardial Infarction 03/2022 - 05/2006
10	Obesity 01/2020 - 01/2007
9	Type 2 Diabetes Mellitus (MODY) 05/2022 - 06/2009
9	Atherosclerosis 04/2022 - 10/2014
8	Cognitive Dysfunction 01/2022 - 12/2016
8	Albuminuria 11/2020 - 02/2015
7	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 05/2009
7	Weight Loss (Weight Reduction) 01/2018 - 01/2004
6	Mesothelioma 04/2022 - 02/2009
6	Renal Insufficiency (Renal Failure) 01/2022 - 03/2002
6	Genetic Risk Score 01/2022 - 02/2016
6	Coronary Disease (Coronary Heart Disease) 12/2021 - 09/2003
6	Body Weight (Weight, Body) 02/2021 - 01/2013
6	Diabetes Mellitus 08/2017 - 05/2006
5	Dyslipidemias (Dyslipidemia) 05/2022 - 12/2003
5	Infections 01/2019 - 01/2013
5	Phenylketonurias (Phenylketonuria) 11/2015 - 01/2014
5	Abdominal Obesity 07/2014 - 02/2004
4	Fibrosis (Cirrhosis) 02/2022 - 01/2019
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2017
4	Asthma (Bronchial Asthma) 01/2022 - 01/2017
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2018
4	Heart Diseases (Heart Disease) 01/2022 - 01/2013
4	Prediabetic State (Prediabetes) 09/2021 - 03/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2018
4	Anemia 09/2020 - 10/2011
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 03/2020 - 07/2013
4	Kidney Diseases (Kidney Disease) 01/2020 - 04/2004
4	Hypotension (Low Blood Pressure) 08/2011 - 02/2004
3	Breast Neoplasms (Breast Cancer) 07/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

86	Antihypertensive Agents (Antihypertensives)IBA 04/2022 - 04/2002
50	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2010
27	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2002
23	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2003
21	CreatinineIBA 01/2022 - 03/2002
20	C-Reactive ProteinIBA 11/2020 - 06/2003
18	SodiumIBA 01/2022 - 07/2002
17	LipidsIBA 05/2022 - 09/2006
14	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2022 - 02/2013
13	Troponin T (Troponin T1)IBA 04/2022 - 05/2013
12	pro-brain natriuretic peptide (1-76)IBA 04/2022 - 02/2013
12	SaltsIBA 01/2022 - 04/2002
11	Hemoglobins (Hemoglobin)IBA 01/2022 - 10/2011
11	HDL CholesterolIBA 02/2021 - 02/2004
10	CholesterolIBA 01/2022 - 07/2004
10	Cystatin CIBA 01/2022 - 10/2011
10	PotassiumIBA 01/2021 - 10/2002
10	AntibodiesIBA 01/2021 - 02/2009
9	Biological ProductsIBA 01/2022 - 01/2007
9	Pharmaceutical PreparationsIBA 01/2022 - 03/2004
9	Dietary SodiumIBA 01/2021 - 07/2002
9	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2015 - 09/2008
8	Insulin (Novolin)FDA Link 02/2021 - 02/2003
8	Fibrinogen (Factor I)FDA Link 01/2019 - 06/2003
7	Growth Differentiation Factor 15IBA 01/2022 - 01/2019
7	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2021 - 08/2017
7	HomocysteineIBA 01/2019 - 06/2003
7	Triglycerides (Triacylglycerol)IBA 01/2019 - 02/2004
6	Galectin 3 (LGALS3)IBA 12/2021 - 01/2018
6	MineralsIBA 12/2021 - 07/2007
6	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 01/2015
5	Fibroblast Growth Factor-23IBA 12/2021 - 06/2011
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2015
5	CalciumIBA 01/2021 - 04/2011
5	Uric Acid (Urate)IBA 11/2020 - 12/2004
5	Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA 11/2015 - 01/2014
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022 - 01/2014
4	LigandsIBA 01/2022 - 04/2011
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2016
4	ApolipoproteinsIBA 09/2021 - 10/2004
4	oxidized low density lipoproteinIBA 09/2021 - 07/2014
4	EnzymesIBA 01/2021 - 01/2015
4	Phosphorus (Red Phosphorus)IBA 01/2021 - 10/2011
4	AlbuminsIBA 11/2020 - 02/2004
4	EndostatinsIBA 11/2020 - 01/2012
4	Immunoglobulin FragmentsIBA 01/2020 - 03/2010
4	AntioxidantsIBA 01/2019 - 03/2002
4	ORALIT (ORS)IBA 01/2019 - 06/2009
4	Catalytic DNA (Deoxyribozyme)IBA 10/2016 - 01/2013
4	Indicators and Reagents (Reagents)IBA 01/2016 - 12/2010
4	MorpholinosIBA 02/2007 - 09/2005
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022 - 01/2014

Therapy/Procedure

39	Therapeutics 01/2022 - 07/2003
6	Drug Therapy (Chemotherapy) 01/2022 - 11/2005
6	Precision Medicine 01/2021 - 03/2016
4	Radiotherapy 04/2022 - 08/2006
4	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 03/2016 - 10/2012
4	Secondary Prevention 08/2015 - 08/2004